There are several non-invasive tests (NITs) for identifing the NASH and/or high risk NAFLD, that is advanced fibrosis patients. There are three kind of NITs, blood biomarkers, scoring sytem such as Fib-4, and imaging. In my presentation I discuss the these three modalities and how to use them in clinical setting.